Erik received his Ph.D. in Toxicology in 2016 from Texas A&M University and has seven years of post-doctoral experience from Texas A&M University and the Lerner Research Institute of the Cleveland Clinic. With fourteen years of molecular toxicology, medical oncology, cell/molecular biology and biochemistry experience, Dr. Hedrick has acquired extensive experience utilizing in vitro and in vivo molecular, biochemical, and analytical techniques as well as animal husbandry in the field of molecular toxicology and oncology. He has published over 20 peer reviewed publications and has received a Merit Scholars Fellowship, National Institute of Health (NIH) Ruth L Kirschstein National Research Service Award (NRSA), and Early Investigator Research Award through the Prostate Cancer Research Program. He has presented at over 20 scientific conferences including annual SOT meetings. Here at Burdock Group, Erik's role is to ensure the safety and regulatory compliance of a client’s product before it comes out onto the market. His experience in toxicology has equipped him with the toolset to understand the unique safety requirements for an ingredient and what tests are needed to demonstrate safety. He is also familiar with specific regulations pertaining to the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) within the United States as well as with the European Food Safety Authority (EFSA) within the European Union (EU).